Skip to main content
MESA LABORATORIES INC /CO/ logo

MESA LABORATORIES INC /CO/ — Investor Relations & Filings

Ticker · MLAB ISIN · US59064R1095 LEI · 549300ZCG738WLX8ZW79 US Manufacturing
Open in API
Filings indexed 1,017 across all filing types
Latest filing 2016-02-02 Regulatory Filings
Country US United States of America
Listing US MLAB

About MESA LABORATORIES INC /CO/

https://mesalabs.com

Mesa Laboratories, Inc. designs, manufactures, and markets quality control products and services for regulated industries. The company specializes in life sciences tools and critical quality control solutions, including analytical instruments and related consumables. Its products are utilized primarily in the pharmaceutical, healthcare, and medical device sectors to ensure product safety, integrity, and performance. Mesa Laboratories focuses on applying technical expertise and technological innovation to help customers monitor and maintain high standards, supporting compliance with various regulatory requirements and international standards for quality management, testing, and calibration.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions that the company issued a press release regarding its financial results for the three and nine months ended December 31, 2015. The document includes a press release as an exhibit but does not contain detailed financial statements or substantive financial data itself. The length is only 2672 characters, which is quite short and consistent with a brief announcement rather than a full financial report. According to the rules, if a document is short and primarily announces or furnishes a press release about financial results without containing the full report, it should be classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other categories. Therefore, this document is best classified as a Regulatory Filing (RNS).
2016-02-02 English
CONESTOGA CAPITAL ADVISORS
Major Shareholding Notification
2016-01-05 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated January 4, 2016, reporting the acquisition of certain assets and liabilities of two European distributors by the company's subsidiary. The content focuses on a corporate event (an acquisition) rather than a full financial report or earnings release. The document includes a press release about the acquisition and signatures but does not contain detailed financial statements or quarterly/yearly financial results. Form 8-K filings are typically used for current reports on significant corporate events, including acquisitions, and are classified under Capital/Financing Update (CAP) when related to financing or capital structure changes or acquisitions. Given the acquisition announcement and the nature of the filing, the most appropriate classification is Capital/Financing Update (CAP). The document length is short and does not contain full financial data, so it is not an Annual Report or Interim Report. Confidence is high due to clear identification of the acquisition event in a Form 8-K.
2016-01-04 English
PRIMARY DOCUMENT
Director's Dealing
2015-12-16 English
PRIMARY DOCUMENT
Director's Dealing
2015-12-08 English
PRIMARY DOCUMENT
Director's Dealing
2015-11-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.